Q4 2021 Holdings
Filed 2022-02-15 | 73 holdings | $62.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $10.8K | 355,088 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $11.6K | 138,100 | 0.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $11.8K | 380,000 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $14.3K | 37,500 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $17.0K | 77,222 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $17.5K | 113,200 | 0.0% |
| PTC Therapuetics COM(PTCT) | COM | 69366J200 | $17.9K | 449,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $18.5K | 126,500 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $19.3K | 139,900 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $20.5K | 282,784 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $20.9K | 285,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $23.8K | 280,000 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $32.6K | 144,746 | 0.1% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $235.0K | 44,000 | 0.4% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $707.0K | 21,500 | 1.1% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $747.0K | 50,000 | 1.2% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $881.0K | 52,800 | 1.4% |
| Ascendis Pharma AS(ASND) | Sponsored ADR | 04351P101 | $4.0M | 29,400 | 6.3% |
| Beigene LTD(ONC) | Sponsored ADR | 07725L102 | $5.4M | 20,000 | 8.7% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $7.6M | 334,500 | 12.3% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $9.3M | 105,156 | 14.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $11.4M | 47,500 | 18.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $21.7M | 128,000 | 34.8% |